Sep 11, 2026 08:01AM
Sep 11, 2026 08:00AM
Mar 24, 2025 08:01AM
Mar 24, 2025 08:00AM
Mar 17, 2025 08:00AM
Mar 17, 2025 08:00AM
Mar 13, 2025 08:33AM Allarity Therapeutics (ALLR) Announces Final Settlement with the U.S. Securities and Exchange Commission
Mar 13, 2025 08:30AM
Mar 6, 2025 08:00AM
Mar 3, 2025 08:01AM
Mar 3, 2025 08:00AM
Feb 26, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 6, 2025 08:01AM Allarity Therapeutics (ALLR) Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
Feb 6, 2025 08:00AM
Jan 30, 2025 08:06AM
Jan 30, 2025 08:00AM
Nov 18, 2024 08:03AM
Nov 18, 2024 08:00AM
Nov 14, 2024 08:00AM
Oct 22, 2024 08:00AM Allarity Therapeutics (ALLR) to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Oct 22, 2024 08:00AM
Oct 10, 2024 08:00AM
Oct 10, 2024 08:00AM
Oct 3, 2024 08:00AM
Sep 16, 2024 08:00AM
Sep 16, 2024 08:00AM
Sep 11, 2024 08:00AM Allarity Therapeutics (ALLR) Announces 1:30 Reverse Share Split
Sep 11, 2024 08:00AM
Jul 26, 2024 09:00AM
Jul 24, 2024 06:02AM
Jul 24, 2024 06:00AM
Jul 22, 2024 06:32AM
Jul 22, 2024 06:30AM
Jun 27, 2024 08:01AM Allarity Therapeutics (ALLR) Granted Hearing to Regain Nasdaq Compliance
Jun 27, 2024 08:00AM
Jun 25, 2024 08:00AM
May 20, 2024 08:02AM
May 20, 2024 08:00AM
May 20, 2024 08:00AM
May 20, 2024 08:00AM
May 14, 2024 04:01PM Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Ba
May 7, 2024 09:30AM
May 6, 2024 08:00AM
May 2, 2024 08:03AM
May 2, 2024 08:00AM
Apr 29, 2024 07:02AM
Apr 29, 2024 07:00AM
Apr 17, 2024 09:17AM Form S-1/A Allarity Therapeutics,
Apr 17, 2024 09:10AM

68,288 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All